eli lilly clinical trials tirzepatide New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Tirzepatide Excites in Obesity Now

According to the Centers for Disease Control and Prevention (CDC), it is best to begin the treatment by losing only 1-2 lbs per week

If that distinction matters to you, finding a provider with affordable compounded tirzepatide should be the priority

Blood pressure monitoring is also important because GLP-1 medications can lower blood pressure in some patients, while high-dose steroids may raise it

Those series, it says, generally report successful weight loss without serious adverse events when providers proceed cautiously and monitor gastrointestinal symptoms

In this scenario, you may need to naturally lower your blood pressure or speak with your doctor about other options

Dupuis, LLC Write A Message If you have any questions, please do not hesitate to send us a message